Aptevo Therapeutics Inc.

APVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Mar 5, 2024 4
4 Mar 5, 2024 4
4 Mar 5, 2024 4
4 Mar 5, 2024 4
10-K Mar 5, 2024 10-K
8-K Mar 5, 2024 8-K
SC 13G Feb 14, 2024
8-K Feb 6, 2024 8-K
4 Jan 30, 2024 4
4 Jan 30, 2024 4
4 Jan 30, 2024 4
DEFR14A Jan 30, 2024 DEFR14A
DEFR14A Jan 16, 2024 DEFR14A
DEF 14A Dec 22, 2023 DEF 14A
PRE 14A Dec 12, 2023 PRE 14A
EFFECT Nov 30, 2023
CORRESP Nov 29, 2023
UPLOAD Nov 29, 2023
S-3 Nov 22, 2023 S-3
10-Q Nov 14, 2023 10-Q
8-K Nov 14, 2023 8-K
8-K Nov 9, 2023 8-K
8-K Nov 3, 2023 8-K
8-K Sep 15, 2023 8-K
4 Aug 10, 2023 FORM 4 SUBMISSION
← Newer Page 11 of 30 · 733 filings Older →